New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease (2024)
- Authors:
- Murta, Silvane M. F.
- Santana, Pedro Augusto Lemos
- Lapierre, thibault Joseph William Jacques Dit
- Penteado, André Berndt
- Hajje, Marissa El
- Liarte, Daniel Barbosa
- Souza, Mariana Laureano de
- Trossini, Gustavo Henrique Goulart
- Rezende Junior, Celso de Oliveira
- Oliveira, Renata Barbosa de
- Ferreira, Rafaela S.
- Murta, Silvane M. F.
- USP affiliated authors: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; PENTEADO, ANDRÉ BERNDT - FCF ; HAJJE, MARISSA EL - FCF
- Unidade: FCF
- DOI: 10.1080/17460441.2024.2349155
- Subjects: TRYPANOSOMA CRUZI; DOENÇA DE CHAGAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Expert Opinion on Drug Discovery
- ISSN: 1746-0441
- Volume/Número/Paginação/Ano: v. 19, n. 6, p. 741-753, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MURTA, Silvane M. F. et al. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease. Expert Opinion on Drug Discovery, v. 19, n. 6, p. 741-753, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/17460441.2024.2349155. Acesso em: 10 fev. 2026. -
APA
Murta, S. M. F., Santana, P. A. L., Lapierre, thibault J. W. J. D., Penteado, A. B., Hajje, M. E., Liarte, D. B., et al. (2024). New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease. Expert Opinion on Drug Discovery, 19( 6), 741-753. doi:10.1080/17460441.2024.2349155 -
NLM
Murta SMF, Santana PAL, Lapierre thibault JWJD, Penteado AB, Hajje ME, Liarte DB, Souza ML de, Trossini GHG, Rezende Junior C de O, Oliveira RB de, Ferreira RS. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease [Internet]. Expert Opinion on Drug Discovery. 2024 ; 19( 6): 741-753.[citado 2026 fev. 10 ] Available from: https://dx.doi.org/10.1080/17460441.2024.2349155 -
Vancouver
Murta SMF, Santana PAL, Lapierre thibault JWJD, Penteado AB, Hajje ME, Liarte DB, Souza ML de, Trossini GHG, Rezende Junior C de O, Oliveira RB de, Ferreira RS. New drug discovery strategies for the treatment of Benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease [Internet]. Expert Opinion on Drug Discovery. 2024 ; 19( 6): 741-753.[citado 2026 fev. 10 ] Available from: https://dx.doi.org/10.1080/17460441.2024.2349155 - SETDB1: an emerging target for anticancer drug development [Editorial]
- Molecular modeling and structural comparison of Leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery
- Docking studies of the Cannabinoids derivatives in O- GlcNAc Transferase (OGT) as anti-cancer candidates
- Binding evolution of the dengue virus envelope against DC-SIGN: a combined approach of Phylogenetics and molecular dynamics analyses over 30 years of dengue virus in Brazil
- The Red Queen hypothesis from a structural perspective: a case study over 30 years of Dengue virus in Brazil
- Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets
- Estudo estrutural e comparativo entre Sirtuínas 2 de diferentes espécies de Leishmania
- Human sirtuin 2 inhibitors, their mechanisms and binding modes
- Structure-Based Virtual Screening: Successes and Pitfalls
- Molecular cloning and characterization of pirarucu (Arapaima gigas) follicle-stimulating hormone and luteinizing hormone β-subunit cDNAs
Informações sobre o DOI: 10.1080/17460441.2024.2349155 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
